Canada markets closed

3-D Matrix, Ltd. (DMTRF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
1.11000.0000 (0.00%)
At close: 08:35AM EST

3-D Matrix, Ltd.

Kojimachi HF Building
7th Floor 3-2-4 Kojimachi Chiyoda-ku
Tokyo 102-0083
Japan
81 3 3511 3440
https://www.3d-matrix.co.jp

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees108

Key Executives

NameTitlePayExercisedYear Born
Mr. Jun OkadaPresident & Representative DirectorN/AN/A1974
Dr. Shuguang Zhang Ph.D.FounderN/AN/AN/A
Mr. Satoru KobayashiHead of Business Development & DirectorN/AN/A1980
Mr. Takao MikiHead of EMEA Business & DirectorN/AN/A1976
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

3-D Matrix, Ltd. develops self-assembling peptide technology in Japan and internationally. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the regenerative medicine, cell therapy, drug delivery systems, and other uses in various fields. The company was incorporated in 2004 and is based in Tokyo, Japan.

Corporate Governance

3-D Matrix, Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.